William Blair & Company’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,292
Closed -$293K 1744
2019
Q3
$293K Buy
6,292
+1,169
+23% +$54.3K ﹤0.01% 1123
2019
Q2
$268K Sell
5,123
-1,186
-19% -$69.6K ﹤0.01% 1187
2019
Q1
$435K Sell
6,309
-557
-8% -$37.3K ﹤0.01% 1004
2018
Q4
$410K Buy
6,866
+1,137
+20% +$98.1K ﹤0.01% 976
2018
Q3
$664K Buy
5,729
+109
+2% +$12.3K ﹤0.01% 868
2018
Q2
$709K Hold
5,620
﹤0.01% 832
2018
Q1
$608K Sell
5,620
-49
-0.9% -$5.42K ﹤0.01% 860
2017
Q4
$621K Sell
5,669
-1,584
-22% -$158K ﹤0.01% 891
2017
Q3
$716K Buy
7,253
+252
+4% +$24.4K 0.01% 815
2017
Q2
$709K Buy
7,001
+1,393
+25% +$150K 0.01% 858
2017
Q1
$647K Sell
5,608
-135
-2% -$15.7K 0.01% 825
2016
Q4
$689K Hold
5,743
0.01% 736
2016
Q3
$645K Buy
5,743
+1,548
+37% +$178K 0.01% 760
2016
Q2
$520K Sell
4,195
-5,515
-57% -$666K ﹤0.01% 794
2016
Q1
$1.09M Buy
9,710
+23
+0.2% +$2.39K 0.01% 602
2015
Q4
$1.05M Buy
+9,687
New +$1.11M 0.01% 617

Other funds holding CLB

William Blair & Company's CLB Position: Q4 2019 in Review

William Blair & Company sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 6,292 shares — an estimated $293K sold.

William Blair & Company first reported a position in CLB in Q4 2015 and held it in 16 quarters. The position peaked at $1.09M in Q1 2016. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • William Blair & Company reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • William Blair & Company sold 6,292 Core Laboratories shares in Q4 2019, an estimated $293K.
  • William Blair & Company first reported a position in Core Laboratories in Q4 2015 and held it in 16 quarters.
  • William Blair & Company's Core Laboratories position peaked at $1.09M in Q1 2016.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on William Blair & Company's 13F filing for Q4 2019, filed 13 Feb 2020.